Cargando…

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity

Non-alcoholic fatty liver disease (NAFLD) constitutes a spectrum of disease states characterized by hepatic steatosis and is closely associated to obesity and the metabolic syndrome. In non-alcoholic steatohepatitis (NASH), additionally, inflammatory changes and hepatocellular damage are present, re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Herck, Mikhaïl A., Weyler, Jonas, Kwanten, Wilhelmus J., Dirinck, Eveline L., De Winter, Benedicte Y., Francque, Sven M., Vonghia, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372559/ https://www.ncbi.nlm.nih.gov/pubmed/30787925 http://dx.doi.org/10.3389/fimmu.2019.00082

Ejemplares similares

Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease
por: Vonghia, Luisa, et al.
Publicado: (2019)

Adoptive Cell Transfer of Regulatory T Cells Exacerbates Hepatic Steatosis in High-Fat High-Fructose Diet-Fed Mice
por: Van Herck, Mikhaïl A., et al.
Publicado: (2020)

Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
por: Van Herck, Mikhaïl A., et al.
Publicado: (2017)

Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes
por: Mertens, Jonathan, et al.
Publicado: (2023)

Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
por: Francque, Sven, et al.
Publicado: (2019)

Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis
por: Verlinden, Wim, et al.
Publicado: (2020)

Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis
por: Van Herck, Mikhaïl A., et al.
Publicado: (2020)

Vasoconstrictor antagonism improves functional and structural vascular alterations and liver damage in rats with early NAFLD
por: van der Graaff, Denise, et al.
Publicado: (2021)

Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy
por: Mertens, Jonathan, et al.
Publicado: (2021)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013)

Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features
por: Vonghia, Luisa, et al.
Publicado: (2015)

Epidemiology and treatment of autoimmune hepatitis
por: Francque, Sven, et al.
Publicado: (2012)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

CD4+RORγt++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2015)

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
por: Duan, Yamei, et al.
Publicado: (2022)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease
por: Stiglund, Natalie, et al.
Publicado: (2019)

Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack
por: Oates, Jarren R., et al.
Publicado: (2019)

Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
por: Martínez-Chantar, María Luz, et al.
Publicado: (2021)

The immune response as a therapeutic target in non-alcoholic fatty liver disease
por: Ortiz-López, Nicolás, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease: A patient guideline
por: Francque, Sven M., et al.
Publicado: (2021)

Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
por: Pan, Xiongfeng, et al.
Publicado: (2020)

The Absence of STING Ameliorates Non-Alcoholic Fatty Liver Disease and Reforms Gut Bacterial Community
por: Zhang, Qiang, et al.
Publicado: (2022)

Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools
por: Meli, Rosaria, et al.
Publicado: (2014)

Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns
por: Zeng, Fanhong, et al.
Publicado: (2021)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Gallego-Durán, Rocío, et al.
Publicado: (2021)

Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
por: Fan, Yadong, et al.
Publicado: (2022)

Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease
por: Oates, Jarren R., et al.
Publicado: (2023)

Psoriasis: Obesity and Fatty Acids
por: Kunz, Manfred, et al.
Publicado: (2019)

Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease
por: Zhou, Liangliang, et al.
Publicado: (2022)

SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
por: Novo, Erica, et al.
Publicado: (2022)

Helminth infection and helminth-derived products: A novel therapeutic option for non-alcoholic fatty liver disease
por: Liu, Xi, et al.
Publicado: (2022)

The association between non-alcoholic fatty liver disease and atopic dermatitis: a population-based cohort study
por: Gau, Shuo-Yan, et al.
Publicado: (2023)

The Liver and the Cardiovascular System: Two of a Kind?
por: Francque, Sven
Publicado: (2021)

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

Innovative liver research continues during the current pandemic
por: Francque, Sven
Publicado: (2020)

Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease
por: Luci, Carmelo, et al.
Publicado: (2019)

Identification of the Non-Alcoholic Fatty Liver Disease Molecular Subtypes Associated With Clinical and Immunological Features via Bioinformatics Methods
por: Liu, Ziyu, et al.
Publicado: (2022)

Risk of liver dysfunction and non-alcoholic fatty liver diseases in people with hidradenitis suppurativa: A systematic review and meta-analysis of real-world evidences
por: Gau, Shuo-Yan, et al.
Publicado: (2022)

Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Yang, Kailin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_902aiqtq4u0a7u2ttp47nh6a07